Human breast milk is an understudied biological fluid that may be useful for early detection of breast cancer. Methods for enriching and detecting biomarkers in human breast milk, however, are not as well-developed as compared with other biological fluids. In this work, we demonstrate a new enrichment method based on polymeric nanoassemblies that is capable of enhancing the mass spectrometry–based detection of peptides and proteins in human breast milk. In this method, positively charged nanoassemblies are used to selectively deplete abundant proteins in milk based on electrostatic interactions, which simplifies the mixture and enhances detection of positively charged peptides and proteins. Negatively charged nanoassemblies are used in a subsequent enrichment step to further enhance the detection and quantification of trace-level peptides and proteins. Together the depletion and enrichment steps allow model biomarkers to be detected at low nM levels, which are close to instrumental limits of detection. This new method not only demonstrates the ability to detect proteins in human breast milk but also provides an alternative approach for targeted protein detection in complex biological matrices.
This is a preview of subscription content, log in to check access.
Buy single article
Instant unlimited access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Stewart B, Wild CP. World Cancer Report 2014, 2014.
Hutchinson L. Challenges, controversies, breakthroughs. Nat Rev Clin Oncol. 2010;7:669–70.
Wulfkuhle JD, Liotta LA, Petricoin EF. Proteomic applications for the early detection of cancer. Nat Rev Cancer. 2003;3:267–75.
Sawyers CL. The cancer biomarker problem. Nature. 2008;452:548–52.
Wu L, Qu X. Cancer biomarker detection: recent achievements and challenges. Chem Soc Rev. 2015;44:2963–97.
Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol. 2006;24:971–83.
Borrebaeck CA. Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer. Nat Rev Cancer. 2017;17:199–204.
Füzéry AK, Levin J, Chan MM, Chan DW. Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges. Clin Proteomics. 2013;10:13.
Crutchfield CA, Thomas SN, Sokoll LJ, Chan DW. Advances in mass spectrometry-based clinical biomarker discovery. Clin Proteomics. 2016;13:1.
Ross JS, Fletcher JA, Linette GP, Stec J, Clark E, Ayers M, et al. The HER-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy. Oncologist. 2003;8:307–25.
Kurono S, Kaneko Y, Matsuura N, Oishi H, Noguchi S, Kim S, et al. Identification of potential breast cancer markers in nipple discharge by protein profile analysis using two-dimensional nano-liquid chromatography/nanoelectrospray ionization-mass spectrometry. Proteomics Clin Appl. 2016;10:605–13.
Schneider SS, Aslebagh R, Ngounou Wetie AG, Sturgeon SR, Darie CC, Arcaro KF. Using breast milk to assess breast vancer risk: the role of mass spectrometry-based proteomics. Adv Exp Med Biol. 2014;806:399–408.
American Cancer Society Breast cancer facts and figures 2013-2014. American Cancer Society, Atlanta, 2013.
Borges VF, Schedin PJ. Pregnancy-associated breast cancer: an entity needing refinement of the definition. Cancer. 2012;118:3226–8.
Callihan EB, Gao D, Jindal S, Lyons TR, Manthey E, Edgerton S, et al. Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer. Breast Cancer Res Treat. 2013;138:549–59.
Wong CM, Anderton DL, Schneider SS, Wing MA, Greven MC, Arcaro KF. Quantitative analysis of promoter methylation in exfoliated epithelial cells isolated from breast milk of healthy women. Epigenetics. 2010;5:645–55.
Browne EP, Punska EC, Lenington S, Otis CN, Anderton DL, Arcaro KF. Increased promoter methylation in exfoliated breast epithelial cells in women with a previous breast biopsy. Epigenetics. 2011;6:1425–35.
Qin W, Zhang K, Kliethermes B, Ruhlen RL, Browne EP, Arcaro KF, et al. Differential expression of cancer associated proteins in breast milk based on age at first full term pregnancy. BMC Cancer. 2012;12:100.
Arcaro KF, Browne EP, Qin W, Zhang K, Anderton DL, Sauter ER. Differential expression of cancer-related proteins in paired breast milk samples from women with breast cancer. J Hum Lact. 2012;28:543–6.
Nimse SB, Sonawane MD, Song K, Kim T. Biomarker detection technologies and future directions. Analyst. 2016;141:740–55.
Penque D. Two-dimensional gel electrophoresis and mass spectrometry for biomarker discovery. Proteomics Clin Appl. 2009;3:155–72.
Kulasingam V, Diamandis EP. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Clin Pract Oncol. 2008;5:588–99.
Miah S, Banks CAS, Adams MK, Florens L, Lukong KE, Washburn MP. Advancement of mass spectrometry-based proteomics technologies to explore triple negative breast cancer. Mol BioSyst. 2017;13:42–55.
Aslebagh R, Channaveerappa D, Arcaro KF, Darie CC. Proteomics analysis of human breast milk to assess breast cancer risk. Electrophoresis. 2018;39:653–65.
Hyun K, Kim J, Gwak H, Jung H. Isolation and enrichment of circulating biomarkers for cancer screening, detection, and diagnostics. Analyst. 2016;141:382–92.
Puangpila C, Mayadunne E, El Rassi Z. Liquid phase based separation systems for depletion, prefractionation, and enrichment of proteins in biological fluids and matrices for in-depth proteomics analysis—an update covering the period 2011-2014. Electrophoresis. 2015;36:238–52.
Abbott KL, Pierce JM. Lectin-based glycoproteomic techniques for the enrichment and identification of potential biomarkers. Methods Enzymol. 2010;480:461–76.
Bossi A, Bonini F, Turner APF, Piletsky SA. Molecularly imprinted polymers for the recognition of proteins: the state of the art. Biosens Bioelectron. 2007;22:1131–7.
Jain P, Vyas MK, Geiger JH, Baker GL, Bruening ML. Protein purification with polymeric affinity membranes containing functionalized poly(acid) brushes. Biomacromolecules. 2010;11:1019–26.
Zhao B, Serrano MAC, Gao J, Zhuang J, Vachet RW, Thayumanavan S. Self-assembly of random co-polymers for selective binding and detection of peptides. Polym Chem. 2018;9:1066–71.
Gao J, Zhao B, Wang M, Serrano MAC, Zhuang J, Ray M, et al. Supramolecular assemblies for transporting proteins across an immiscible solvent interface. J Am Chem Soc. 2018;140:2421–5.
Serrano MAC, Gao J, Kelly KA, Thayumanavan S, Vachet RW. Supramolecular polymeric assemblies for the selective depletion of abundant acidic proteins in serum. ACS Appl Mater Interfaces. 2018;10:40443–51.
Zhao B, Zhuang J, Serrano MAC, Vachet RW, Thayumanavan S. Influence of charge density on host-guest interactions within amphiphilic polymer assemblies in apolar media. Macromolecules. 2017;50:9734–41.
Zhao B, Serrano MAC, Wang M, Liu T, Gordon MR, Thayumanavan S, et al. Improved mass spectrometric detection of acidic peptides by variations in the functional group pKa values of reverse micelle extraction agents. Analyst. 2018;143:1434–43.
Wang M, Zhao B, Gao J, He H, Castellanos LJ, Thayumanavan S, et al. Altering the peptide binding selectivity of polymeric reverse micelle assemblies via metal ion loading. Langmuir. 2017;33:14004–10.
Serrano MAC, Zhao B, He H, Thayumanavan S, Vachet RW. Molecular features influencing the release of peptides from amphiphilic polymeric reverse micelles. Langmuir. 2018;34:4595–602.
Vaudel M, Burkhart JM, Zahedi RP, Oveland E, Berven FS, Sickmann A, et al. PeptideShaker enables reanalysis of MS-derived proteomics data sets. Nat Biotechnol. 2015;33:22–4.
Ballard O, Morrow AL. Human milk composition: nutrients and bioactive factors. Pediatr Clin N Am. 2013;60:49–74.
Gross SJ, Geller J, Tomarelli RM. Composition of breast milk from mothers of preterm infants. Pediatrics. 1981;68:490–3.
Böttcher MF, Jenmalm MC, Garofalo RP, Björkstén B. Cytokines in breast milk from allergic and nonallergic mothers. Pediatr Res. 2000;47:157.
Pang W, Hartmann PE. Initiation of human lactation: secretory differentiation and secretory activation. J Mammary Gland Biol Neoplasia. 2007;12:211–21.
Castellote C, Casillas R, Ramirez-Santana C, Perez-Cano FJ, Castell M, Moretones MG, et al. Premature delivery influences the immunological composition of colostrum and transitional and mature human milk. J Nutr. 2011;141:1181–7.
Verd S, Ginovart G, Calvo J, Ponce-Taylor J, Gaya A. Variation in the protein composition of human milk during extended lactation: a narrative review. Nutrients. 2018;10:1124.
Conflict of interest
The authors declare that they have no conflicts of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
About this article
Cite this article
Zhao, B., Gao, J., Serrano, M.A.C. et al. Polymeric nanoassemblies for enrichment and detection of peptides and proteins in human breast milk. Anal Bioanal Chem (2020). https://doi.org/10.1007/s00216-019-02342-8
- Breast milk
- Mass spectrometry
- Protein enrichment